Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron J Friedman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Physical Review Letters|November 9, 2019
Integrable Many-Body Quantum Floquet-Thouless PumpsAaron J Friedman, Sarang Gopalakrishnan, Romain Vasseur
Journal of Chemical Information and Modeling|September 14, 2011
CrystalDock: a novel approach to fragment-based drug designJacob D Durrant, Aaron J Friedman, J Andrew McCammon
Physical Review Letters|December 22, 2021
Subdiffusion and Many-Body Quantum Chaos with Kinetic ConstraintsHansveer Singh, Brayden A Ware, Romain Vasseur, et al.
Physical Review Letters|December 7, 2019
Spectral Statistics and Many-Body Quantum Chaos with Conserved ChargeAaron J Friedman, Amos Chan, Andrea De Luca, et al.
Journal of Chemical Information and Modeling|June 6, 2013
Comparing neural-network scoring functions and the state of the art: applications to common library screeningJacob D Durrant, Aaron J Friedman, Kathleen E Rogers, et al.
Journal of Natural Products|December 25, 2013
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin LBailey Miller, Aaron J Friedman, Hyukjae Choi, et al.
The Journal of Investigative Dermatology|October 3, 2009
Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation after transplantation to athymic miceJennifer M Klingenberg, Kevin L McFarland, Aaron J Friedman, et al.
Chemical Biology & Drug Design|April 11, 2012
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessAaron J Friedman, Jacob D Durrant, Levi C T Pierce, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Physical Review Letters|November 9, 2019
Integrable Many-Body Quantum Floquet-Thouless PumpsAaron J Friedman, Sarang Gopalakrishnan, Romain Vasseur
Journal of Chemical Information and Modeling|September 14, 2011
CrystalDock: a novel approach to fragment-based drug designJacob D Durrant, Aaron J Friedman, J Andrew McCammon
Physical Review Letters|December 22, 2021
Subdiffusion and Many-Body Quantum Chaos with Kinetic ConstraintsHansveer Singh, Brayden A Ware, Romain Vasseur, et al.
Physical Review Letters|December 7, 2019
Spectral Statistics and Many-Body Quantum Chaos with Conserved ChargeAaron J Friedman, Amos Chan, Andrea De Luca, et al.
Journal of Chemical Information and Modeling|June 6, 2013
Comparing neural-network scoring functions and the state of the art: applications to common library screeningJacob D Durrant, Aaron J Friedman, Kathleen E Rogers, et al.
Journal of Natural Products|December 25, 2013
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin LBailey Miller, Aaron J Friedman, Hyukjae Choi, et al.
The Journal of Investigative Dermatology|October 3, 2009
Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation after transplantation to athymic miceJennifer M Klingenberg, Kevin L McFarland, Aaron J Friedman, et al.
Chemical Biology & Drug Design|April 11, 2012
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessAaron J Friedman, Jacob D Durrant, Levi C T Pierce, et al.
Pageof 1